Shu, Ditian
Huang, Riqing
Chen, Meiting
Li, Haifeng
An, Xin
Xue, Cong
Hu, Anqi
Zhou, Fangjian
Yao, Kai
Liu, Zhuowei
Shi, Yanxia
Funding for this research was provided by:
National Key Research and Development Program of China (2021YFE0206300)
National Natural Science Foundation of China (No. 82403969, No. 82073391, No. 81773279)
Article History
Received: 21 October 2024
Accepted: 2 April 2025
First Online: 16 April 2025
Declarations
:
: The clinical data were acquired with the approval and permission of the Institutional Review Board of the Sun Yat-sen University Cancer Center. The study protocol was approved by the ethical committee of Sun Yat-sen University Cancer Center (approval number B2022 - 268 - 01), and the study was performed according to the principles of the Declaration of Helsinki. Informed consent was not required because this study was a retrospective analysis of clinical data and posed no human biological ethical issues. Therefore, the need for informed consent was waived by the ethical committee of the Sun Yat-sen University Cancer Center. All methods were performed following relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.